Ads
related to: canadian drug companies prices
Search results
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical...
Morningstar· 18 hours agoCompany” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, ...
Rakovina Therapeutics: AI a “paradigm shift” for cancer drug development
Proactive Investors· 15 hours agoRakovina Therapeutics Inc (TSX-V:RKV), a Canadian biotechnology company focused on developing...
Newspaper headlines: Labour's 'vow to nationalise rail' and school stabbing
BBC via Yahoo News· 1 hour agoThe Scottish edition of the Times says a quarter of boys in Scotland have smoked cannabis. The...
AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 2 days agoFusion has a diversified pipeline...to begin in 2025. For the acquisition, AstraZeneca will pay a ...
Purpose Canadian Financial Income Fund Series ETF (TSE:BNC) Stock Price Crosses Above 200 Day Moving...
ETF DAILY NEWS· 2 days agoPurpose Canadian Financial Income Fund Series ETF (TSE:BNC – Get Free Report) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving ...
UCLA Benefits Handsomely From Xtandi Cancer Drug Royalties Amid Controversy Over Drug Pricing
Los Angeles Magazine· 6 days agoUCLA, reaping billions from the cancer drug Xtandi developed with public funds, opposes U.S. plans...
Metro’s Q2 profits dip, but sales rise 2.2%
Supermarket News· 10 hours agoCanadian retailer Metro Inc. said Wednesday that second quarter net income was down compared with a year ago as it transitioned into two new automated...
Knights of Columbus Asset Advisors LLC Decreases Stock Position in Canadian National Railway...
ETF DAILY NEWS· 3 days agoThe institutional investor owned 2,088 shares of the transportation company’s stock after selling 190 shares during the quarter. Knights of Columbus Asset Advisors LLC’s holdings ...
It Introduced Ozempic to the World. Now It Must Remake Itself.
The New York Times via Yahoo News· 5 days agoJorgensen is CEO of Novo Nordisk, a Danish drugmaker. Even if the company isn’t quite a household...
Brokerages Set BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Target Price at $16.86
ETF DAILY NEWS· 3 days agoBioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Free Report) has earned an average recommendation of “Hold” from the seven brokerages that are covering the company, Marketbeat ...
